Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Take-home Functional Electrical Stimulation for MDD

NCT: NCT06261177 · ACTIVE_NOT_RECRUITING

NCT IDNCT06261177
StatusACTIVE_NOT_RECRUITING
Start Date2023-12-04
Completion2028-09
SponsorUnity Health Toronto (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to learn whether Functional Electrical Stimulation (FES) of the facial muscles is effective in treating major depressive disorder (MDD) and to develop a model for take-home delivery.

Frequently Asked Questions

What is Take-home Functional Electrical Stimulation for MDD?

Take-home Functional Electrical Stimulation for MDD is a clinical trial registered under NCT06261177. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06261177?

The current status of NCT06261177 (Take-home Functional Electrical Stimulation for MDD) is: ACTIVE_NOT_RECRUITING.

When did Take-home Functional Electrical Stimulation for MDD start?

Take-home Functional Electrical Stimulation for MDD started on 2023-12-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑